Annual CAPEX
$865.00 K
-$4.81 M-84.76%
31 December 2023
Summary:
Nektar Therapeutics annual capital expenditures is currently $865.00 thousand, with the most recent change of -$4.81 million (-84.76%) on 31 December 2023. During the last 3 years, it has fallen by -$6.39 million (-88.08%). NKTR annual CAPEX is now -98.39% below its all-time high of $53.85 million, reached on 31 December 2000.NKTR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$666.00 K
+$480.00 K+258.06%
30 September 2024
Summary:
Nektar Therapeutics quarterly capital expenditures is currently $666.00 thousand, with the most recent change of +$480.00 thousand (+258.06%) on 30 September 2024. Over the past year, it has increased by +$633.00 thousand (+1918.18%). NKTR quarterly CAPEX is now -96.16% below its all-time high of $17.36 million, reached on 30 June 2000.NKTR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.25 M
+$633.00 K+103.26%
30 September 2024
Summary:
Nektar Therapeutics TTM capital expenditures is currently $1.25 million, with the most recent change of +$633.00 thousand (+103.26%) on 30 September 2024. Over the past year, it has increased by +$106.00 thousand (+9.30%). NKTR TTM CAPEX is now -97.69% below its all-time high of $53.85 million, reached on 31 December 2000.NKTR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.8% | +1918.2% | +9.3% |
| 3 y3 years | -88.1% | -77.3% | -88.5% |
| 5 y5 years | -93.9% | -87.5% | -96.0% |
NKTR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.2% | at low | -88.7% | +1918.2% | -92.4% | +111.5% |
| 5 y | 5 years | -96.7% | at low | -88.7% | +1918.2% | -96.0% | +111.5% |
| alltime | all time | -98.4% | at low | -96.2% | -97.7% | +523.0% |
Nektar Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $666.00 K(+258.1%) | $1.25 M(+103.3%) |
| June 2024 | - | $186.00 K(+18.5%) | $613.00 K(+4.1%) |
| Mar 2024 | - | $157.00 K(-33.8%) | $589.00 K(-31.9%) |
| Dec 2023 | $865.00 K(-84.8%) | $237.00 K(+618.2%) | $865.00 K(-24.1%) |
| Sept 2023 | - | $33.00 K(-79.6%) | $1.14 M(-11.5%) |
| June 2023 | - | $162.00 K(-62.6%) | $1.29 M(-32.4%) |
| Mar 2023 | - | $433.00 K(-15.4%) | $1.91 M(-66.4%) |
| Dec 2022 | $5.68 M(-62.1%) | $512.00 K(+182.9%) | $5.68 M(-48.7%) |
| Sept 2022 | - | $181.00 K(-76.8%) | $11.06 M(-19.9%) |
| June 2022 | - | $780.00 K(-81.4%) | $13.81 M(-15.3%) |
| Mar 2022 | - | $4.20 M(-28.7%) | $16.32 M(+8.9%) |
| Dec 2021 | $14.99 M(+106.5%) | $5.90 M(+100.8%) | $14.99 M(+38.2%) |
| Sept 2021 | - | $2.94 M(-10.5%) | $10.85 M(+10.4%) |
| June 2021 | - | $3.28 M(+14.1%) | $9.82 M(+6.4%) |
| Mar 2021 | - | $2.88 M(+64.0%) | $9.23 M(+27.2%) |
| Dec 2020 | $7.26 M(-72.4%) | $1.75 M(-8.2%) | $7.26 M(-20.9%) |
| Sept 2020 | - | $1.91 M(-29.1%) | $9.18 M(-27.1%) |
| June 2020 | - | $2.69 M(+199.3%) | $12.59 M(-41.6%) |
| Mar 2020 | - | $900.00 K(-75.5%) | $21.54 M(-18.1%) |
| Dec 2019 | $26.29 M(+84.6%) | $3.67 M(-31.0%) | $26.29 M(-16.0%) |
| Sept 2019 | - | $5.32 M(-54.3%) | $31.30 M(+12.6%) |
| June 2019 | - | $11.64 M(+106.1%) | $27.80 M(+47.1%) |
| Mar 2019 | - | $5.65 M(-35.0%) | $18.90 M(+32.7%) |
| Dec 2018 | $14.24 M(+47.2%) | $8.69 M(+376.8%) | $14.24 M(+79.2%) |
| Sept 2018 | - | $1.82 M(-33.6%) | $7.95 M(+12.5%) |
| June 2018 | - | $2.75 M(+178.7%) | $7.06 M(+7.5%) |
| Mar 2018 | - | $985.00 K(-58.8%) | $6.57 M(-32.1%) |
| Dec 2017 | $9.68 M(+51.4%) | $2.39 M(+154.8%) | $9.68 M(-2.6%) |
| Sept 2017 | - | $939.00 K(-58.4%) | $9.93 M(+4.5%) |
| June 2017 | - | $2.25 M(-44.9%) | $9.50 M(+8.0%) |
| Mar 2017 | - | $4.09 M(+54.2%) | $8.80 M(+37.7%) |
| Dec 2016 | $6.39 M(-42.9%) | $2.65 M(+422.9%) | $6.39 M(+2.9%) |
| Sept 2016 | - | $507.00 K(-67.4%) | $6.21 M(-36.9%) |
| June 2016 | - | $1.55 M(-7.4%) | $9.85 M(-16.7%) |
| Mar 2016 | - | $1.68 M(-32.1%) | $11.81 M(+5.5%) |
| Dec 2015 | $11.20 M(+12.2%) | $2.47 M(-40.2%) | $11.20 M(-11.2%) |
| Sept 2015 | - | $4.14 M(+17.4%) | $12.61 M(+34.6%) |
| June 2015 | - | $3.52 M(+232.9%) | $9.37 M(+43.9%) |
| Mar 2015 | - | $1.06 M(-72.7%) | $6.51 M(-34.7%) |
| Dec 2014 | $9.98 M(+143.9%) | $3.89 M(+332.7%) | $9.98 M(+13.4%) |
| Sept 2014 | - | $898.00 K(+34.4%) | $8.80 M(+3.7%) |
| June 2014 | - | $668.00 K(-85.2%) | $8.49 M(+2.3%) |
| Mar 2014 | - | $4.52 M(+67.0%) | $8.30 M(+102.9%) |
| Dec 2013 | $4.09 M(-61.3%) | $2.71 M(+360.7%) | $4.09 M(-34.2%) |
| Sept 2013 | - | $588.00 K(+23.0%) | $6.22 M(-24.2%) |
| June 2013 | - | $478.00 K(+51.3%) | $8.21 M(-12.6%) |
| Mar 2013 | - | $316.00 K(-93.5%) | $9.38 M(-11.3%) |
| Dec 2012 | $10.58 M(+8.9%) | $4.84 M(+88.1%) | $10.58 M(+47.6%) |
| Sept 2012 | - | $2.57 M(+55.3%) | $7.17 M(+18.6%) |
| June 2012 | - | $1.66 M(+9.2%) | $6.05 M(-19.1%) |
| Mar 2012 | - | $1.52 M(+6.2%) | $7.47 M(-23.1%) |
| Dec 2011 | $9.72 M(-69.1%) | $1.43 M(-1.4%) | $9.72 M(-44.7%) |
| Sept 2011 | - | $1.45 M(-53.0%) | $17.59 M(-40.4%) |
| June 2011 | - | $3.08 M(-18.2%) | $29.51 M(-5.6%) |
| Mar 2011 | - | $3.77 M(-59.5%) | $31.25 M(-0.7%) |
| Dec 2010 | $31.46 M(+52.0%) | $9.30 M(-30.4%) | $31.46 M(-2.0%) |
| Sept 2010 | - | $13.36 M(+177.1%) | $32.10 M(+49.3%) |
| June 2010 | - | $4.82 M(+21.4%) | $21.50 M(+9.9%) |
| Mar 2010 | - | $3.97 M(-60.0%) | $19.57 M(-5.5%) |
| Dec 2009 | $20.70 M | $9.94 M(+259.6%) | $20.70 M(+42.2%) |
| Sept 2009 | - | $2.76 M(-4.5%) | $14.55 M(-11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $2.90 M(-43.3%) | $16.50 M(-11.6%) |
| Mar 2009 | - | $5.10 M(+34.6%) | $18.68 M(-0.9%) |
| Dec 2008 | $18.86 M(-42.5%) | $3.79 M(-19.6%) | $18.86 M(-30.5%) |
| Sept 2008 | - | $4.71 M(-7.0%) | $27.13 M(-14.1%) |
| June 2008 | - | $5.07 M(-4.0%) | $31.60 M(-2.8%) |
| Mar 2008 | - | $5.28 M(-56.2%) | $32.52 M(-0.8%) |
| Dec 2007 | $32.80 M(+45.6%) | $12.07 M(+31.4%) | $32.80 M(+20.5%) |
| Sept 2007 | - | $9.18 M(+53.4%) | $27.23 M(+20.9%) |
| June 2007 | - | $5.99 M(+7.8%) | $22.53 M(-4.1%) |
| Mar 2007 | - | $5.56 M(-14.5%) | $23.49 M(+4.3%) |
| Dec 2006 | $22.52 M(+25.4%) | $6.50 M(+45.0%) | $22.52 M(-0.8%) |
| Sept 2006 | - | $4.48 M(-35.5%) | $22.72 M(+5.9%) |
| June 2006 | - | $6.95 M(+51.5%) | $21.44 M(+19.0%) |
| Mar 2006 | - | $4.59 M(-31.5%) | $18.01 M(+0.3%) |
| Dec 2005 | $17.95 M(-34.0%) | $6.69 M(+108.7%) | $17.95 M(-1.2%) |
| Sept 2005 | - | $3.21 M(-8.9%) | $18.16 M(-14.4%) |
| June 2005 | - | $3.52 M(-22.3%) | $21.22 M(-12.5%) |
| Mar 2005 | - | $4.53 M(-34.4%) | $24.24 M(-10.9%) |
| Dec 2004 | $27.19 M(+45.1%) | $6.90 M(+10.2%) | $27.19 M(-4.1%) |
| Sept 2004 | - | $6.26 M(-4.3%) | $28.35 M(+6.2%) |
| June 2004 | - | $6.54 M(-12.6%) | $26.69 M(+11.7%) |
| Mar 2004 | - | $7.49 M(-7.1%) | $23.90 M(+27.5%) |
| Dec 2003 | $18.75 M(+14.8%) | $8.06 M(+74.9%) | $18.75 M(+25.5%) |
| Sept 2003 | - | $4.61 M(+22.7%) | $14.94 M(+23.6%) |
| June 2003 | - | $3.75 M(+61.0%) | $12.09 M(-13.2%) |
| Mar 2003 | - | $2.33 M(-45.2%) | $13.94 M(-14.6%) |
| Dec 2002 | $16.33 M(-52.4%) | $4.25 M(+142.1%) | $16.33 M(-17.7%) |
| Sept 2002 | - | $1.76 M(-68.6%) | $19.84 M(-24.7%) |
| June 2002 | - | $5.60 M(+18.6%) | $26.36 M(-8.9%) |
| Mar 2002 | - | $4.72 M(-39.2%) | $28.92 M(-15.7%) |
| Dec 2001 | $34.32 M(-36.3%) | $7.76 M(-6.2%) | $34.32 M(-8.2%) |
| Sept 2001 | - | $8.27 M(+1.3%) | $37.37 M(-9.3%) |
| June 2001 | - | $8.17 M(-19.3%) | $41.20 M(-18.2%) |
| Mar 2001 | - | $10.12 M(-6.4%) | $50.39 M(-6.4%) |
| Dec 2000 | $53.85 M(+162.7%) | $10.81 M(-10.6%) | $53.85 M(+1.3%) |
| Sept 2000 | - | $12.10 M(-30.3%) | $53.14 M(+27.9%) |
| June 2000 | - | $17.36 M(+27.8%) | $41.54 M(+46.6%) |
| Mar 2000 | - | $13.58 M(+34.5%) | $28.34 M(+38.2%) |
| Dec 1999 | $20.50 M(-40.7%) | $10.10 M(+1920.4%) | $20.50 M(-12.7%) |
| Sept 1999 | - | $500.00 K(-88.0%) | $23.48 M(-17.1%) |
| June 1999 | - | $4.16 M(-27.6%) | $28.33 M(-10.2%) |
| Mar 1999 | - | $5.74 M(-56.1%) | $31.55 M(-8.8%) |
| Dec 1998 | $34.58 M(+100.4%) | $13.08 M(+144.9%) | $34.58 M(+13.1%) |
| Sept 1998 | - | $5.34 M(-27.7%) | $30.57 M(+3.6%) |
| June 1998 | - | $7.38 M(-15.8%) | $29.50 M(+17.4%) |
| Mar 1998 | - | $8.77 M(-3.2%) | $25.14 M(+45.6%) |
| Dec 1997 | $17.26 M(+684.6%) | $9.06 M(+111.9%) | $17.26 M(+96.2%) |
| Sept 1997 | - | $4.28 M(+41.6%) | $8.80 M(+71.8%) |
| June 1997 | - | $3.02 M(+236.4%) | $5.12 M(+83.0%) |
| Mar 1997 | - | $898.00 K(+49.7%) | $2.80 M(+27.2%) |
| Dec 1996 | $2.20 M(+69.2%) | $600.00 K(0.0%) | $2.20 M(+10.0%) |
| Sept 1996 | - | $600.00 K(-14.3%) | $2.00 M(+17.6%) |
| June 1996 | - | $700.00 K(+133.3%) | $1.70 M(+41.7%) |
| Mar 1996 | - | $300.00 K(-25.0%) | $1.20 M(-7.7%) |
| Dec 1995 | $1.30 M(-7.1%) | $400.00 K(+33.3%) | $1.30 M(+8.3%) |
| Sept 1995 | - | $300.00 K(+50.0%) | $1.20 M(-33.3%) |
| June 1995 | - | $200.00 K(-50.0%) | $1.80 M(+12.5%) |
| Mar 1995 | - | $400.00 K(+33.3%) | $1.60 M(+14.3%) |
| Dec 1994 | $1.40 M | $300.00 K(-66.7%) | $1.40 M(+27.3%) |
| Sept 1994 | - | $900.00 K(>+9900.0%) | $1.10 M(+450.0%) |
| June 1994 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Mar 1994 | - | $200.00 K | $200.00 K |
FAQ
- What is Nektar Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Nektar Therapeutics?
- What is Nektar Therapeutics annual CAPEX year-on-year change?
- What is Nektar Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly CAPEX year-on-year change?
- What is Nektar Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Nektar Therapeutics?
- What is Nektar Therapeutics TTM CAPEX year-on-year change?
What is Nektar Therapeutics annual capital expenditures?
The current annual CAPEX of NKTR is $865.00 K
What is the all time high annual CAPEX for Nektar Therapeutics?
Nektar Therapeutics all-time high annual capital expenditures is $53.85 M
What is Nektar Therapeutics annual CAPEX year-on-year change?
Over the past year, NKTR annual capital expenditures has changed by -$4.81 M (-84.76%)
What is Nektar Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of NKTR is $666.00 K
What is the all time high quarterly CAPEX for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly capital expenditures is $17.36 M
What is Nektar Therapeutics quarterly CAPEX year-on-year change?
Over the past year, NKTR quarterly capital expenditures has changed by +$633.00 K (+1918.18%)
What is Nektar Therapeutics TTM capital expenditures?
The current TTM CAPEX of NKTR is $1.25 M
What is the all time high TTM CAPEX for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM capital expenditures is $53.85 M
What is Nektar Therapeutics TTM CAPEX year-on-year change?
Over the past year, NKTR TTM capital expenditures has changed by +$106.00 K (+9.30%)